Royalty Pharma EVP Research & Investments Marshall Urist sells $235,594 of Class A shares

• Royalty Pharma EVP, Research & Investments Marshall Urist sold 4,126 Class A ordinary shares on Oct. 5, 2026 at USD 57.1.
• Direct holdings fell to 0 shares.
• He reported 19,020 Class A ordinary shares held indirectly through an IRA.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001838139-26-000028), on October 05, 2026, and is solely responsible for the information contained therein.